Review article · 2026 · Open access
Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers
Journal of Controlled Release, 400(Pt B), 115524 · Published 4 November 2026 · DOI 10.1016/j.jconrel.2026.115524
In brief
“Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers” is a 2026 review article by Nagavendra Kommineni and 6 co-authors, published in Journal of Controlled Release. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Journal of Controlled Release.
- Citations
- 0
- References
- 64
- Authors
- 7
Abstract
Intravaginal HIV prevention has progressed from early nonspecific microbicides to antiretroviral gels, films, inserts, and intravaginal rings, alongside emerging biologic agents and multipurpose prevention technologies (MPTs). Despite substantial advances in antiviral potency and formulation technology, translation from pharmaceutical development to consistent clinical protection has remained uneven, indicating that API activity or dosage-form performance alone is insufficient to explain clinical outcomes. This review critically examines the development of intravaginal HIV prevention and MPT products through a mechanistic pharmaceutical perspective, focusing on the relationships between controllable product attributes, drug release and transport, the cervicovaginal environment, compartment-specific pharmacokinetics/pharmacodynamics (PK/PD), and product use. Historical microbicide and antiretroviral programs are examined as translational case studies to identify how mucosal safety, local exposure and use-dependent drug delivery contributed to divergent clinical outcomes. The review further evaluates how cervicovaginal fluid, semen, mucus, epithelial barriers, hormonal state, microbiome composition, and inflammation can modify formulation behavior and drug transport; how API physicochemistry, solid state, drug loading, drug-polymer partitioning, and diffusivity constrain formulation architecture and release; and how these relationships differ among gels, films, inserts, sustained-release devices, MPTs, and biologic delivery systems. Particular attention is given to the distinction between drug incorporation, release, tissue transport, and pharmacologically relevant exposure, and to the additional challenges created when multiple APIs require different release rates, biological compartments, or durations of action. Platform characteristics are further considered in relation to the exposure patterns and product-use conditions they are intended to support. By integrating formulation science with cervicovaginal physiology, PK/PD, and clinical experience, this review provides a mechanistic basis for identifying where intravaginal prevention systems lose translational performance and which formulation-transport-exposure relationships require stronger evidence to support more reproducible clinical protection.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Kommineni, N., Jyothi, V. G. S., Katta, C., Mahumane, G. D., Ilomuanya, M. O., Choonara, Y., & Angsantikul, P. (2026). Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers. Journal of Controlled Release, 400(Pt B), 115524. https://doi.org/10.1016/j.jconrel.2026.115524
MLA 9
Kommineni, Nagavendra, et al. “Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers.” Journal of Controlled Release, vol. 400, no. Pt B, 2026, p. 115524. https://doi.org/10.1016/j.jconrel.2026.115524.
Chicago
Kommineni, Nagavendra, Vaskuri G.S. Sainaga Jyothi, Chanti Katta, Gillian Dumsile Mahumane, Margaret Okonawan Ilomuanya, Yahya Choonara, and Pavimol Angsantikul. 2026. “Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers.” Journal of Controlled Release 400 (Pt B): 115524. https://doi.org/10.1016/j.jconrel.2026.115524.
Harvard
Kommineni, N. et al. (2026) ‘Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers’, Journal of Controlled Release, 400(Pt B), p. 115524. doi:10.1016/j.jconrel.2026.115524.
IEEE
N. Kommineni et al., “Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers,” Journal of Controlled Release, vol. 400, no. Pt B, p. 115524, 2026, doi: 10.1016/j.jconrel.2026.115524.
BibTeX
@article{kommineni2026translational,
title = {{Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers}},
author = {Kommineni, Nagavendra and Jyothi, Vaskuri G.S. Sainaga and Katta, Chanti and Mahumane, Gillian Dumsile and Ilomuanya, Margaret Okonawan and Choonara, Yahya and Angsantikul, Pavimol},
journal = {Journal of Controlled Release},
year = {2026},
volume = {400},
number = {Pt B},
pages = {115524},
doi = {10.1016/j.jconrel.2026.115524},
url = {https://doi.org/10.1016/j.jconrel.2026.115524}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- multipurpose prevention technologies
- microbicides
- intravaginal ring
- vaginal drug delivery
- pharmacokinetics/pharmacodynamics
- cervicovaginal microbiome
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Kommineni, N., Jyothi, V. G. S., Katta, C., Mahumane, G. D., Ilomuanya, M. O., Choonara, Y., & Angsantikul, P. (2026). Translational resilience in intravaginal HIV prevention and multipurpose prevention technologies: formulation, exposure, and implementation barriers. Journal of Controlled Release, 400(Pt B), 115524. https://doi.org/10.1016/j.jconrel.2026.115524
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Controlled Release: sign in and open the full text from this page.
Who wrote this paper?
Nagavendra Kommineni, Vaskuri G.S. Sainaga Jyothi, Chanti Katta, Gillian Dumsile Mahumane, Margaret Okonawan Ilomuanya, Yahya Choonara, Pavimol Angsantikul.
What is the DOI of this paper?
10.1016/j.jconrel.2026.115524, permanently at https://doi.org/10.1016/j.jconrel.2026.115524. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.